Cigna Corp Stock Research

Market Summary

USD244.10-2.97

Market Closed

-1.20%

CI Alerts

2 major insider sales recently.

CI Stock Price

CI RSI Chart

CI Valuation

Market Cap

91.1B

Price/Earnings (Trailing)

13.64

Price/Sales (Trailing)

1.92

EV/EBITDA

8.96

Price/Free Cashflow

8.41

CI Price/Sales (Trailing)

CI Profitability

EBT Margin

4.63%

Return on Equity

15.03%

Return on Assets

4.69%

Free Cashflow Yield

11.89%

CI Fundamentals

CI Revenue

Revenue (TTM)

183.0B

Revenue Y/Y

5.71%

Revenue Q/Q

1.67%

CI Earnings

Earnings (TTM)

6.7B

Earnings Y/Y

5.74%

Earnings Q/Q

-56.88%

Price Action

52 Week Range

237.34338.66

(Low)(High)

CI Financial Health

Current Ratio

0.73

Debt/Equity

0.63

Debt/Cashflow

0.31

CI Investor Care

Dividend Yield

1.88%

Dividend/Share (TTM)

4.59

Diluted EPS (TTM)

21.99

Peers (Alternatives to Cigna)

View All Peers In Detail

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	448.8B	335.9B	-	-	21.68	1.34	12.90%	18.65%
CI	91.1B	183.0B	-	-	13.64	1.92	3.34%	24.58%
HUM	65.7B	95.6B	-	-	23.41	0.71	10.74%	2.64%
CNC	34.6B	146.3B	-	-	23.33	0.24	9.81%	-0.94%
MID-CAP
LHCG	5.2B	2.3B	-	-	86.23	2.28	2.85%	-58.05%
HQY	4.7B	861.7M	-	-	-178.64	5.42	13.90%	40.97%
AMN	3.9B	4.8B	-	-	10.12	0.8	3.57%	-4.88%
CRVL	3.4B	704.5M	-	-	49.59	4.78	13.56%	10.15%
PDCO	2.6B	6.4B	-	-	13.26	0.41	-0.52%	16.73%
SMALL-CAP
RDNT	1.7B	1.5B	-	-	-126.07	1.14	10.24%	-173.11%
ADUS	1.4B	976.1M	-	-	28.65	1.47	10.19%	12.37%
BKD	645.6M	2.9B	-	-	-3.53	0.22	7.97%	-101.02%

Financials for Cigna

* denotes actual numbers (not divided by Millions)
Income Statement (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Revenue	1.4%	183,028	180,516	180,453	179,461	177,112
S&GA Expenses	1.8%	13,425	13,186	13,365	13,310	13,050
EBITDA	0.1%	12,519	12,508	8,189	11,032	-
EBITDA Margin	0.1%	0.07*	0.07*	0.18*	0.06*	-
Earnings Before Taxes	0.6%	8,405	8,353	8,337	6,905	6,818
EBT Margin	0.2%	0.05*	0.05*	0.15*	0.04*	-
Interest Expenses	1.1%	1,243	1,229	1,226	1,229	1,230
Net Income	1.0%	6,746	6,681	5,538	5,442	-
Net Income Margin	0.9%	0.04*	0.04*	0.12*	0.03*	-
Free Cahsflow	-20.1%	8,656	10,832	9,668	8,128	-

* denotes actual numbers (not divided by Millions)
Balance Sheet					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Assets	2.8%	147,976	143,932	144,209	152,630	152,610
Current Assets	6.3%	32,027	30,120	30,170	37,422	35,393
Cash Equivalents	34.9%	7,989	5,924	7,079	4,421	4,424
Inventory	-11.8%	4,211	4,777	4,017	3,781	3,500
Goodwill	0%	45,811	45,811	45,807	45,810	45,804
Liabilities	4.4%	103,380	98,981	99,076	106,663	106,446
Current Liabilities	8.5%	44,727	41,229	41,115	45,218	43,662
Long Term Debt	3.6%	29,124	28,100	28,090	30,984	31,013
Shareholder's Equity	-0.8%	44,518	44,872	45,041	45,922	46,109
Retained Earnings	2.6%	38,841	37,874	37,041	34,626	33,420
Additional Paid-In Capital	0.3%	30,332	30,233	29,395	29,930	29,736
Minority Interest	23.1%	16.00	13.00	42.00	30.00	22.00

Cashflow (Last 12 Months)					(In Millions)
Description	(%) Q/Q	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1
Cashflow From Operations	34.6%	11,654	8,656	10,832	9,668	8,128
Cashflow From Investing	-85.8%	439	3,098	3,837	-1,319	-3,218
Cashflow From Financing	19.0%	-9,106	-11,240	-10,975	-7,186	-6,332
Buy Backs	-5.3%	7,201	7,607	7,295	6,406	6,316

Risks for CI

What is the probability of a big loss on CI?

null%

Probability that Cigna stock will be more than 20% underwater in next one year

null%

Probability that Cigna stock will be more than 30% underwater in next one year.

null%

Probability that Cigna stock will be more than 40% underwater in next one year.

*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does CI drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Cigna was unfortunately bought at previous high price.

Drawdowns

Returns for CI

Cumulative Returns on CI

What are the long-term rolling returns for CI?

FIve years rolling returns for Cigna.

Annualized Returns

Which funds bought or sold CI recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
2023-05-26	ProShare Advisors LLC	added	11.58	-2,215,320	13,667,800	0.04%
2023-05-25	Brandywine Global Investment Management, LLC	added	183	99,677,800	183,856,000	0.74%
2023-05-25	Empower Advisory Group, LLC	new	-	1,064,240	1,064,240	-%
2023-05-24	Old North State Trust, LLC	unchanged	-	-2,000	6,000	-%
2023-05-23	Toroso Investments, LLC	added	70.44	1,390,000	5,814,000	0.10%
2023-05-23	3Chopt Investment Partners, LLC	new	-	2,536,200	2,536,200	1.35%
2023-05-23	Brookfield Corp /ON/	added	2.84	-3,875,990	14,858,300	0.06%
2023-05-23	Front Row Advisors LLC	reduced	-16.84	-11,000	20,000	0.01%
2023-05-22	AMERIPRISE FINANCIAL INC	added	22.73	-62,839,300	1,110,600,000	0.36%
2023-05-22	American Trust	reduced	-72.95	-913,348	240,709	0.02%

Latest Funds Activity

Are funds buying CI calls or puts?

Calls

Puts

Are funds bullish or bearish(Calls - Puts)?

Net Call Options

No. of funds that own CI

No. of Funds

CI Alerts

2 major insider sales recently.

Cigna News

Schedule 13G FIlings of Cigna

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2023	dodge & cox	3.8%	11,548,557	SC 13G/A
Feb 14, 2023	price t rowe associates inc /md/	4.5%	13,656,608	SC 13G/A
Feb 09, 2023	fmr llc	-	0	SC 13G
Feb 09, 2023	vanguard group inc	8.37%	25,583,766	SC 13G/A
Feb 07, 2023	blackrock inc.	9.0%	27,469,496	SC 13G
Feb 14, 2022	dodge & cox	5.3%	17,484,197	SC 13G
Feb 14, 2022	price t rowe associates inc /md/	5.4%	17,961,332	SC 13G/A
Feb 09, 2022	vanguard group inc	7.88%	26,120,848	SC 13G/A
Feb 09, 2022	fmr llc	-	0	SC 13G/A
Feb 03, 2022	blackrock inc.	8.9%	29,587,276	SC 13G/A

CI Fair Value

Recent SEC filings of Cigna

View All Filings

Date Filed	Form Type	Document
May 24, 2023	4	Insider Trading
May 10, 2023	4	Insider Trading
May 05, 2023	10-Q	Quarterly Report
May 05, 2023	8-K	Current Report
May 03, 2023	4	Insider Trading
May 01, 2023	144	Notice of Insider Sale Intent
May 01, 2023	8-K	Current Report
Apr 28, 2023	8-K	Current Report
Apr 28, 2023	4	Insider Trading
Apr 28, 2023	4	Insider Trading

Latest Insider Trading transactions for CI

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
2023-05-22	Agoglia Hoeltzel Mary T	sold	-128,374	254	-503	svp tax & chief acct. officer
2023-05-08	Palmer Eric P	gifted	-	-	390	president & ceo, evernorth
2023-05-08	Palmer Eric P	gifted	-	-	-390	president & ceo, evernorth
2023-05-01	ZARCONE DONNA F	sold	-191,741	253	-757	-
2023-04-26	McClellan Mark B.	acquired	-	-	765	-
2023-04-26	MAZZARELLA KATHLEEN M	acquired	-	-	765	-
2023-04-26	DeLaney William J III	acquired	-	-	765	-
2023-04-26	Granger Elder	acquired	-	-	765	-
2023-04-26	Hathi Neesha	acquired	-	-	765	-
2023-04-26	Kurian George	acquired	-	-	765	-

About Cigna

David M. Cordani

www.cigna.com

65535

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

CI Income Statement

2023-03-31

Consolidated Statements of Income - USD ($)
$ in Millions

3 Months Ended

Mar. 31, 2023

Mar. 31, 2022

^[1]

Revenues

Premiums

$ 11,025

$ 10,356

Net investment income

277

414

TOTAL REVENUES

46,517

44,006

Benefits and expenses

Pharmacy and other service costs

31,459

29,813

Medical costs and other benefit expenses

9,046

8,272

Selling, general and administrative expenses

3,538

3,275

Amortization of acquired intangible assets

459

458

TOTAL BENEFITS AND EXPENSES

44,502

41,818

Income from operations

2,015

2,188

Interest expense and other

(358)

(299)

Net realized investment losses

(56)

(322)

Income before income taxes

1,601

1,567

TOTAL INCOME TAXES

295

355

Net income

1,306

1,212

Less: Net income attributable to noncontrolling interests

SHAREHOLDERS' NET INCOME

$ 1,267

$ 1,197

Shareholders' net income per share

Basic (in dollars per share)

$ 4.28

$ 3.76

Diluted (in dollars per share)

$ 4.24

$ 3.73

Pharmacy revenues

Revenues

Revenues

$ 32,144

$ 30,697

Fees and other revenues

Revenues

Revenues

$ 3,071

$ 2,539

[1]	Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.

CI Balance Sheet

2023-03-31

Consolidated Balance Sheets - USD ($)
$ in Millions

Mar. 31, 2023

Dec. 31, 2022

^[1]

Assets

Cash and cash equivalents

$ 7,935

$ 5,924

Investments

914

905

Accounts receivable, net

17,704

17,218

Inventories

4,211

4,777

Other current assets

1,263

1,298

Total current assets

32,027

30,122

Long-term investments

19,010

16,288

Reinsurance recoverables

5,286

5,416

Property and equipment

3,837

3,774

Goodwill

45,811

Other intangible assets

32,102

32,492

Other assets

2,563

2,704

Separate account assets

7,340

7,278

TOTAL ASSETS

147,976

143,885

Liabilities

Current insurance and contractholder liabilities

7,166

5,409

Pharmacy and other service costs payable

17,609

17,070

Accounts payable

7,360

7,775

Accrued expenses and other liabilities

9,174

7,978

Short-term debt

3,418

2,993

Total current liabilities

44,727

41,225

Non-current insurance and contractholder liabilities

11,790

11,976

Deferred tax liabilities, net

7,707

7,786

Other non-current liabilities

2,692

2,766

Long-term debt

29,124

28,100

Separate account liabilities

7,340

7,278

TOTAL LIABILITIES

103,380

99,131

Contingencies — Note 16

Redeemable noncontrolling interests

Shareholders' equity

Common stock

^[2]

Additional paid-in capital

30,332

30,233

Accumulated other comprehensive loss

(1,769)

(1,658)

Retained earnings

38,841

37,940

Less: Treasury stock, at cost

(22,906)

(21,844)

TOTAL SHAREHOLDERS' EQUITY

44,502

44,675

Other noncontrolling interests

Total equity

44,518

44,688

^[3]

Total liabilities and equity

$ 147,976

$ 143,885

[1]	Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements for further information.
[2]	Par value per share, $0.01; shares issued, 399 million as of March 31, 2023 and 398 million as of December 31, 2022; authorized shares, 600 million.
[3]	Amounts have been restated to reflect the adoption of Targeted Improvements to the Accounting for Long-Duration Contracts in 2023. See Note 2 to the Consolidated Financial Statements to the Consolidated Financial Statements for further information.